| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |